| 000 | 01639 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513041640.0 | ||
| 264 | 0 | _c19950601 | |
| 008 | 199506s 0 0 eng d | ||
| 022 | _a1053-2498 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMacdonald, P S | |
| 245 | 0 | 0 |
_aA double-blind placebo-controlled trial of low-dose ganciclovir to prevent cytomegalovirus disease after heart transplantation. _h[electronic resource] |
| 260 |
_bThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation _c |
||
| 300 |
_a32-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aActuarial Analysis |
| 650 | 0 | 4 |
_aCytomegalovirus _xisolation & purification |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xepidemiology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGanciclovir _xadministration & dosage |
| 650 | 0 | 4 | _aHeart Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aKeogh, A M | |
| 700 | 1 | _aMarshman, D | |
| 700 | 1 | _aRichens, D | |
| 700 | 1 | _aHarvison, A | |
| 700 | 1 | _aKaan, A M | |
| 700 | 1 | _aSpratt, P M | |
| 773 | 0 |
_tThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation _gvol. 14 _gno. 1 Pt 1 _gp. 32-8 |
|
| 999 |
_c7726839 _d7726839 |
||